Search results

Selected filters:

United States of America
Valuation

Article type

Topic

Sector

219 results found for your search

Sort options
09 January 2020

NPE’s litigation move may be a sign of things to come in the healthcare sector

Move by Parallax Health Sciences is an indication that patent assertion plays could increasingly affect life sciences companies as their use of digital technologies increases

02 January 2020

Why the traditional US model of educating tomorrow’s lawyers must change

Intellectual property systems are becoming more complex and that makes law schools’ one-size-fits all approach looks increasingly out of date, says Franklin Pierce dean

17 December 2019

Intel puts connected devices patent portfolio up for sale

After deal for cellular chip business with Apple, the company places rest of the assets that were on the market in the summer back on the auction block

17 December 2019

US NPE leverages China litigation to secure Xiaomi deal

Acacia sub-licensor scored a global deal with smartphone maker as key rights neared expiration

12 December 2019

Seoul Semiconductor patent auction analysis reveals a mixed bag of assets

In sales due to be held this month and next, the Korean company offers two radically different portfolios. But value is in the eye of the beholder - and a range of businesses could be making bids

10 December 2019

How the threat of unsold rights, the rise of the in-house dealmaker and a revolution in analytics are re-shaping the IP deals market

As IAM releases this year's brokered patent market survey one of its authors digs deep into the current climate for transactions and explains why some of the grunt work of five years ago is a thing of the past

05 December 2019

Auto IP stakeholders in Asia call for peace, prepare for war

Huawei, Nokia and top Japanese brands discussed the licensing conflicts confronting the industry in front of a packed room in Shanghai

29 November 2019

The 2019 brokered patent market from the buyer and seller perspective

Asking prices for patents are up from last year. However, the size of the market is down and assertion activity from NPEs may be on the rise

29 November 2019

The 2019 brokered patent market

Richardson Oliver Insights highlights a shrinking market, but rising asset prices in its annual breakdown of the deals landscape

28 November 2019

Apple’s IP chief takes top place in this year’s <em>IAM</em> Market Makers list

Jeff Myers heads the 40-strong selection of the global dealmaking elite thanks in no small part to the iPhone giant’s huge Intel patent play in the summer

19 November 2019

Second listing sees Alibaba on firmer IP footing

The e-commerce giant prices its Hong Kong offering this week. Five years after its NYSE debut, it has a more formidable patent portfolio and new IP-based alliances

14 November 2019

Skyhawk deal with Celgene confirms growing importance of platform technologies in life sciences IP value creation

Increased focus on gene and cell-related therapies as well as falling R&D returns, promise to heighten biopharma interest in tapping into the potential of SkySTAR and other platforms

08 November 2019

Catch up on the most important life sciences IP developments from the past month

Read our most recent monthly round-up for key pharma and biotech IP stories from October 2019

05 November 2019

TSMC chief speaks as market reacts to foundry war settlement

Exact terms remain confidential, but TSMC's CEO suggested to employees that the licence rights are not transferrable should Globalfoundries be acquired

25 October 2019

GlobalFoundries’ patent attack on TSMC may have come too late  

In-depth analysis shows that the Taiwanese semiconductor business has not only bulked up its portfolio over the last decade, but also considerably improved its quality